224 related articles for article (PubMed ID: 24219920)
21. Effects of pharmaceuticals and personal care products (PPCPs) on multixenobiotic resistance (MXR) related efflux transporter activity in zebrafish (Danio rerio) embryos.
Cunha V; Burkhardt-Medicke K; Wellner P; Santos MM; Moradas-Ferreira P; Luckenbach T; Ferreira M
Ecotoxicol Environ Saf; 2017 Feb; 136():14-23. PubMed ID: 27810576
[TBL] [Abstract][Full Text] [Related]
22. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
23. CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells.
Enguita-Germán M; Schiapparelli P; Rey JA; Castresana JS
Tumour Biol; 2010 Oct; 31(5):381-90. PubMed ID: 20480407
[TBL] [Abstract][Full Text] [Related]
24. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
25. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
Chen Y; Bieber MM; Teng NN
Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
[TBL] [Abstract][Full Text] [Related]
26. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
27. MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1.
Xu QF; Pan YW; Li LC; Zhou Z; Huang QL; Pang JC; Zhu XP; Ren Y; Yang H; Ohgaki H; Lv SQ
Brain Pathol; 2014 Nov; 24(6):568-83. PubMed ID: 24576181
[TBL] [Abstract][Full Text] [Related]
28. Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
Chen KH; Hsu CC; Song WS; Huang CS; Tsai CC; Kuo CD; Hsu HS; Tsai TH; Tsai CY; Woung LC; Chiou SH; Lu KH; Chen YW
Childs Nerv Syst; 2010 Nov; 26(11):1605-12. PubMed ID: 20526717
[TBL] [Abstract][Full Text] [Related]
29. Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma.
Bhatia S; Hirsch K; Bukkapatnam S; Baig NA; Oweida A; Griego A; Calame D; Sharma J; Donson A; Foreman N; Albanese C; Venkataraman S; Vibhakar R; Karam SD
Cancer Cell Int; 2017; 17():41. PubMed ID: 28360821
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
31. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
[TBL] [Abstract][Full Text] [Related]
32. RalA is overactivated in medulloblastoma.
Ginn KF; Fangman B; Terai K; Wise A; Ziazadeh D; Shah K; Gartrell R; Ricke B; Kimura K; Mathur S; Borrego-Diaz E; Farassati F
J Neurooncol; 2016 Oct; 130(1):99-110. PubMed ID: 27566179
[TBL] [Abstract][Full Text] [Related]
33. Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy.
Huang L; Perrault C; Coelho-Martins J; Hu C; Dulong C; Varna M; Liu J; Jin J; Soria C; Cazin L; Janin A; Li H; Varin R; Lu H
J Hematol Oncol; 2013 Jul; 6():49. PubMed ID: 23837843
[TBL] [Abstract][Full Text] [Related]
34. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
[TBL] [Abstract][Full Text] [Related]
35. Isolation, enrichment, and maintenance of medulloblastoma stem cells.
Huang X; Ketova T; Litingtung Y; Chiang C
J Vis Exp; 2010 Sep; (43):. PubMed ID: 20834221
[TBL] [Abstract][Full Text] [Related]
36. Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature.
Taylor L; Wade PK; Johnson JEC; Aldighieri M; Morlando S; Di Leva G; Kerr ID; Coyle B
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831428
[TBL] [Abstract][Full Text] [Related]
37. ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome.
Wang W; Lokman NA; Noye TM; Macpherson AM; Oehler MK; Ricciardelli C
Cancer Drug Resist; 2021; 4(2):485-502. PubMed ID: 35582032
[No Abstract] [Full Text] [Related]
38. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
39. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
40. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
Aguilera DG; Das CM; Sinnappah-Kang ND; Joyce C; Taylor PH; Wen S; Hasselblatt M; Paulus W; Fuller G; Wolff JE; Gopalakrishnan V
J Neurooncol; 2009 Jul; 93(3):303-18. PubMed ID: 19148581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
